| Literature DB >> 23072472 |
Tao Wang1, Bruce S Gardiner, Zhen Lin, Jonas Rubenson, Thomas B Kirk, Allan Wang, Jiake Xu, David W Smith, David G Lloyd, Ming H Zheng.
Abstract
Tendon and ligament injury is a worldwide health problem, but the treatment options remain limited. Tendon and ligament engineering might provide an alternative tissue source for the surgical replacement of injured tendon. A bioreactor provides a controllable environment enabling the systematic study of specific biological, biochemical, and biomechanical requirements to design and manufacture engineered tendon/ligament tissue. Furthermore, the tendon/ligament bioreactor system can provide a suitable culture environment, which mimics the dynamics of the in vivo environment for tendon/ligament maturation. For clinical settings, bioreactors also have the advantages of less-contamination risk, high reproducibility of cell propagation by minimizing manual operation, and a consistent end product. In this review, we identify the key components, design preferences, and criteria that are required for the development of an ideal bioreactor for engineering tendons and ligaments.Entities:
Mesh:
Year: 2012 PMID: 23072472 PMCID: PMC3589869 DOI: 10.1089/ten.TEB.2012.0295
Source DB: PubMed Journal: Tissue Eng Part B Rev ISSN: 1937-3368 Impact factor: 6.389